Alan MacKay

Alan MacKay General Information

Biography

Mr. Alan MacKay is a Co-Founder and serves as Managing Partner at GHO Capital. He serves as a Board Member at Sterling Pharma Solutions. He serves as Chairman at Ardena. He serves as a Board Member at X-Chem, Linimed, Alcaliber, RoslinCT, and Alcami. He also serves as an Investment Committee Member at Angel CoFund. He served as an Advisor of Gresham House Strategic Public Equity and a Board Member at Lykan Bioscience. Previously, he served as a Board Member at Quotient Sciences. He has been a private equity investor for 30 years in roles including Senior Partner and Global Head of Healthcare at the private equity firm 3i Group plc. He was appointed to the board of 3i plc in 1993 and became CEO of 3i Nordic plc, based in Stockholm, upon the acquisition of Sweden's largest listed private equity company Atle AB in 2001. He has served on the boards of several healthcare companies, including most recently Phibro Animal Health Corporation which completed a successful initial public offering (IPO) in April 2014. He was the Managing Partner, CEO, and Chairman of the Investment Committee, of Hermes GPE, an active co-investor in private equity-backed healthcare. He holds a Bachelor's degree in Law and an MSc in Enterprise and is a graduate of the Advanced Management Programme at INSEAD. He was Chair of the BVCA for 2016 - 2017 and has chaired its Responsible Investment Advisory Board.